Live Poll Results — In the 2016 EpiPen pricing controversy, what pricing strategy did Mylan employ t
See real-time poll results. Powered by AIPolls.Net.
Pharmaceutical Pricing Strategies: The EpiPen Controversy
In 2016, a major pharmaceutical company faced significant backlash after implementing a dramatic price increase on a life-saving medical device. This case study highlights the complex intersection of pricing strategies in medicine, public health needs, and corporate profit considerations. Test your knowledge about this famous pricing controversy that sparked national debate on healthcare affordability and pharmaceutical industry practices.
In the 2016 EpiPen pricing controversy, what pricing strategy did Mylan employ that caused public outrage when they increased the price from $100 to over $600?
Poll Type: Trivia | Total Votes: 0
| Option | Votes | Percentage |
|---|---|---|
| {'choice_text': 'Price skimming - gradually lowering prices over time after initial high markup', 'is_correct': False} | 0 | 0% |
| {'choice_text': 'Inelastic demand exploitation - dramatically raising prices on essential products with few substitutes', 'is_correct': True} | 0 | 0% |
| {'choice_text': 'Loss leader pricing - selling EpiPens below cost to increase hospital contracts', 'is_correct': False} | 0 | 0% |
| {'choice_text': 'Psychological pricing - setting prices just below round numbers to create perception of value', 'is_correct': False} | 0 | 0% |